Search results
Stopping the march: Can effective treatment of psoriasis prevent progression to psoriatic arthritis?
Medical Xpress· 1 day agoPsoriatic arthritis (PsA) is a chronic inflammatory arthritis which appears in around one-third of...
Exploring whether different joints have different treatment outcomes in cases of psoriatic arthritis
Medical Xpress· 1 day agoThere are many treatment options for psoriatic arthritis (PsA), and EULAR—The European Alliance of...
Achieving drug-free remission in axial spondyloarthritis: Exploring the role of tight control in...
Medical Xpress· 58 minutes agoEarly therapeutic interventions in inflammatory rheumatic diseases have proven successful in...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
Oklahoma Voice via Yahoo News· 4 hours agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive via Yahoo Finance· 3 days agoBoth medicines are TYK2 inhibitors, a group of oral medicines that drugmakers are positioning as...
The Best Products For Treating Psoriasis, According To Dermatologists
HuffPost· 1 day ago“[It] commonly arises on the scalp, ears, elbows, knees and nails,” she said. “In addition to the...
EULAR 2024 Preview: What's Not to Miss?
Medscape· 4 days agoEULAR 2024 Preview: What's Not to Miss at This Year's Congress? The European Alliance of Associations for Rheumatology (EULAR) 2024 European Congress of...
Inebilizumab 'MITIGATES' Flare Risk in IgG4-Related Disease
Medscape· 7 days agoInebilizumab-cdon reduced the risk for flares by 87% in patients with IgG4-RD, the MITIGATE study showed.
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 6 days agoSkyrizi is already approved in the United States and the EU for treating plaque psoriasis, psoriatic...
Cresset Asset Management LLC Lowers Position in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 3 days agoCresset Asset Management LLC cut its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities ...